Development of drug loaded nanoparticles for tumor targeting. Part 2: Enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models

被引:50
|
作者
El-Dakdouki, Mohammad H. [1 ]
Pure, Ellen [2 ]
Huang, Xuefei [1 ]
机构
[1] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA
[2] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
SOLID TUMORS; MULTICELLULAR SPHEROIDS; MULTIDRUG-RESISTANCE; TISSUE PENETRATION; GOLD NANOPARTICLES; ANTICANCER DRUGS; CANCER-THERAPY; IN-VIVO; CELLS; DELIVERY;
D O I
10.1039/c3nr90022c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We report that receptor mediated transcytosis can be utilized to facilitate tumor penetration by drug loaded nanoparticles (NPs). We synthesized hyaluronan (HA) coated silica nanoparticles (SNPs) containing a highly fluorescent core to target CD44 expressed on the cancer cell surface. Although prior studies have primarily focused on CD44 mediated endocytosis to facilitate cellular uptake of HA-NPs by cancer cells, we discovered that, once internalized, the HA-SNPs could be transported out of the cells with their cargo. The exported NPs could be taken up by neighboring cells. This enabled the HA-SNPs to penetrate deeper inside tumors and reach a much greater number of tumor cells in 3D tumor models, presumably through tandem cycles of CD44 mediated endocytosis and exocytosis. When doxorubicin (DOX) was loaded onto the NPs, better penetration of multilayered tumor cells was observed with much improved cytotoxicities against both drug sensitive and drug resistant cancer spheroids compared to the free drug. Thus, targeting receptors such as CD44 that can readily undergo recycling between the cell surface and interior of the cells can become a useful strategy to enhance the tumor penetration potential of NPs and the efficiency of drug delivery through receptor mediated transcytosis.
引用
收藏
页码:3904 / 3911
页数:8
相关论文
共 50 条
  • [41] Development of an in Vitro 3D Tumor Model to Study Therapeutic Efficiency of an Anticancer Drug
    Shin, Crystal S.
    Kwak, Bongseop
    Han, Bumsoo
    Park, Kinam
    MOLECULAR PHARMACEUTICS, 2013, 10 (06) : 2167 - 2175
  • [42] Nanofibrillar cellulose hydrogel as 3D culture matrix towards the development of tumor models
    Sheard, Jonathan
    CANCER RESEARCH, 2020, 80 (16)
  • [43] Towards Radiotherapy Enhancement and Real Time Tumor Radiation Dosimetry Through 3D Imaging of Gold Nanoparticles Using XFCT
    Vienne, Caroline
    Stolidi, Adrien
    Lemaire, Hermine
    Maier, Daniel
    Renaud, Diana
    Grall, Romain
    Chevillard, Sylvie
    Brun, Emilie
    Sicard, Cecile
    Limousin, Olivier
    MEDICAL IMAGE COMPUTING AND COMPUTER ASSISTED INTERVENTION - MICCAI 2018, PT I, 2018, 11070 : 401 - 409
  • [44] Curcumin nanoparticles combined with 3D printed bionic tumor models for breast cancer treatment
    Su, Ya
    Hu, Xueyan
    Kang, Yue
    Zhang, Cheng
    Cheng, Yuen Yee
    Jiao, Zeren
    Nie, Yi
    Song, Kedong
    BIOFABRICATION, 2023, 15 (01)
  • [45] Novel 3D bioprinted pancreatic tumor models for anti-cancer drug assessment
    Gaikwad, Shreyas Ramchandra
    Srivastava, Sanjay K.
    CANCER RESEARCH, 2023, 83 (07)
  • [46] 3D Tumor models in drug discovery for high throughput analysis of immune cell infiltration
    Halder, Tithi Ghosh
    Rheinschmidt, Shelby
    Thode, Trason
    Sampson, Samuel
    Del Villar, Ryan Rodriguez
    Ng, Serina
    Weston, Alexis
    Kaadige, Mohan
    Trent, Jeffery
    Altin, John
    Moser, Justin
    Borazanci, Erkut
    Gordon, Michael
    Larson, Anna
    Soldi, Raffaella
    Sharma, Sunil
    CANCER RESEARCH, 2022, 82 (12)
  • [47] 3D NEUROBLASTOMA TUMOR-SPHERE MODELS FOR DRUG SCREENING AND CELL MIGRATION ASSESSMENT
    Law, Laalaa Hiu Tung
    Chan, Godfrey Chi Fung
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [48] Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
    Wei, Qing
    Yang, Teng
    Zhu, Jiayu
    Zhang, Ziwen
    Yang, Le
    Zhang, Yuchao
    Hu, Can
    Chen, Jiahui
    Wang, Jinchao
    Tian, Xuefei
    Shimura, Takaya
    Fang, Jianmin
    Ying, Jieer
    Fan, Mengyang
    Guo, Peng
    Cheng, Xiangdong
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 984 - 997
  • [49] Developing New Peptides and Peptide-Drug Conjugates for Targeting the FGFR2 Receptor-Expressing Tumor Cells and 3D Spheroids
    Biggs, Mary A.
    Das, Amrita
    Goncalves, Beatriz G.
    Murray, Molly E.
    Frantzeskos, Sophia A.
    Hunt, Hannah L.
    Phan, Chau Ahn N.
    Banerjee, Ipsita A.
    BIOMIMETICS, 2024, 9 (09)
  • [50] Exploring tumor microenvironment in lung cancer through patient-derived 3D models
    Juciute, N.
    Boada-Acosta, L. A.
    Torres-Martinez, S.
    Escorihuela, E.
    Maravilla, E. Munera
    Mosqueda-Frometa, M.
    Castellote-Borrell, M.
    Rodriguez, A.
    Miranda, N.
    Roz, L.
    Navarro-Cervero, L.
    Blanco, B.
    Guasch, J.
    Guijarro, R.
    Pastor-Martinez, E.
    Calabuig Farinas, S.
    Camps Herrero, C.
    Jantus Lewintre, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1158 - S1159